Verified Nov 2026
Other
·

Ahmedabad, Gujarat
·
Since 1976
Intas Pharmaceuticals is an Indian multinational generic pharmaceutical manufacturer founded in 1976, headquartered in Ahmedabad, Gujarat, with 10,000–50,000 employees and estimated revenue of $1–5 billion. The company develops and manufactures generic drugs, biosimilars, and complex injectables for medical, automotive, and industrial equipment sectors across 85–100 countries. Recent licensing agreements include a partnership for a proposed golimumab biosimilar and a complex peptide product commercialization deal.
Intas Pharmaceuticals at a glance
Revenue
$1-5B
Est. band
Employees
10,000-50,000
Founded
1976
Headquarters
Ahmedabad, Gujarat
Import activity
17
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
17
Named foreign suppliers
2
Top origins
Mexico · Spain

Shared foreign counterparties do not establish that these companies buy from Intas Pharmaceuticals.
What this tells a buyer
Intas received approximately 15,900 shipments from suppliers in Mexico and Spain, with the majority sourced from a Mexican pharmaceutical distributor.
The company manufactures active pharmaceutical ingredients, oral solid doses, injectables, and biosimilars, with capabilities spanning oncology, central nervous system, cardiodiabetic, rheumatology, and hormone-based therapies.
As privately owned generic pharmaceutical company in India, Intas ranks 6th in the Indian pharmaceutical market and generates a significant portion of revenue from regulated international markets in the EU and US.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
50 years in operation (founded 1976).
17 US import shipments on record.
Overview
Intas Pharmaceuticals is an Indian multinational generic pharmaceutical manufacturer founded in 1976, headquartered in Ahmedabad, Gujarat, with 10,000–50,000 employees and estimated revenue of $1–5 billion. The company develops and manufactures generic drugs, biosimilars, and complex injectables for medical, automotive, and industrial equipment sectors across 85–100 countries. Recent licensing agreements include a partnership for a proposed golimumab biosimilar and a complex peptide product commercialization deal.
At a glance
Attribute | Detail |
|---|---|
Founded | 1976 |
Headquarters | Ahmedabad, Gujarat |
Employees | 10,000-50,000 |
Revenue | $1-5B (estimated) |
What Intas Pharmaceuticals makes
The company manufactures active pharmaceutical ingredients, oral solid doses, injectables, and biosimilars, with capabilities spanning oncology, central nervous system, cardiodiabetic, rheumatology, and hormone-based therapies.
Trade and customs footprint
Intas received approximately 15,900 shipments from suppliers in Mexico and Spain, with the majority sourced from a Mexican pharmaceutical distributor. US customs bill-of-lading records list 17 inbound shipments across 2 foreign suppliers, with top origins including Mexico · Spain.
Latest developments
2026-04-01 — Intas pharmaceuticals | Radio Compass News | PharmaCompass.com (pharmacompass.com)
2026-03-23 — Bio-Thera Solutions Announces Further Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in India | Company News | Bio-Thera (bio-thera.com)
2026-02-09 — Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing and Supply Agreement for Complex Peptide Product in Europe, the UK & India (businesswire.com)
2025-10-09 — Bio-Thera Solutions Announces Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in Canada (prnewswire.com)
2025-08-11 — Intas & Accord signs Agreement to acquire Prothya Biosolutions (prnewswire.com)
2025-08-06 — Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition of UDENYCA® (prnewswire.com)
Facilities
Intas Pharmaceuticals is headquartered in Ahmedabad, Gujarat. Public sources also reference these locations:
India — intaspharma.com
Gujarat, India — intaspharma.com
India, UK — intasb2b.com
Company details
As privately owned generic pharmaceutical company in India, Intas ranks 6th in the Indian pharmaceutical market and generates a significant portion of revenue from regulated international markets in the EU and US. Intas Pharmaceuticals was founded in 1976, has an estimated 10,000-50,000 employees, and is headquartered in Ahmedabad, Gujarat. On the LightSource stability read it is rated "Established & active": 50 years in operation (founded 1976). 17 US import shipments on record.
Frequently asked questions
What does Intas Pharmaceuticals do?
Intas Pharmaceuticals is an Indian multinational generic pharmaceutical manufacturer founded in 1976, headquartered in Ahmedabad, Gujarat, with 10,000–50,000 employees and estimated revenue of $1–5 billion. The company develops and manufactures generic drugs, biosimilars, and complex injectables for medical, automotive, and industrial equipment sectors across 85–100 countries. Recent licensing agreements include a partnership for a proposed golimumab biosimilar and a complex peptide product commercialization deal.
Where is Intas Pharmaceuticals headquartered?
Intas Pharmaceuticals is headquartered in Ahmedabad, Gujarat (Express Highway Junction, Ahmedabad, Gujarat).
When was Intas Pharmaceuticals founded?
Intas Pharmaceuticals was founded in 1976.
How big is Intas Pharmaceuticals?
Intas Pharmaceuticals has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).
Does Intas Pharmaceuticals import from overseas suppliers?
US customs bill-of-lading records show 17 inbound shipments for Intas Pharmaceuticals, with top origins including Mexico · Spain.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
